Further studies need to be designed to evaluate the impact of systemic conditions/diseases on periostin levels that could confound the diagnosis of periodontitis and could benefit targeted screening of high-risk groups with systemic diseases and periodontitis. This evidence concerns the gene POSTN and periodontitis.